Drug Eluding Cardiac Stents

The Veterans Integrated Service Network (VISN 19) is seeking to establish a sole source contract with Boston Scientific Inc for the consignment of drug-eluting cardiac stents, specifically the Paclitaxel drug-eluting stents under the TAXUS brand, for use at the VA Eastern Colorado Health Care System in Denver. Boston Scientific is believed to be the only current provider of these specific stents, which justifies the pursuit of a sole source contract under the Federal Acquisition Regulation provision 6.302-1(b)(1)(i). The contracting office is open to considering other suppliers who can meet the required specifications and invites potential contractors to submit written documentation for consideration. Responses to this solicitation must be sent to Glenda Walton, Contract Specialist at the VISN 19 Rocky Mountain Consolidated Contracting Center, by June 15, 2004, at 4:30 PM. The contracting office handling this procurement is located in Greenwood Village, Colorado, under the Department of Veterans Affairs’ Network Contract Office 19. The solicitation for these drug-eluting cardiac stents was posted on May 20, 2004, under solicitation number VA-SNOTE-040520-002. This contract aims to secure the supply of these specialized medical devices to support cardiac care within the VA healthcare system in the region.